The World Bank Implementation Status & Results Report
Ethiopia COVID-19 Emergency Response (P173750)
Ethiopia COVID-19 Emergency Response (P173750)
EASTERN AND SOUTHERN AFRICA | Ethiopia | Health, Nutrition & Population Global Practice |
IBRD/IDA | Investment Project Financing | FY 2020 | Seq No: 8 | ARCHIVED on 03-Oct-2023 | ISR57730 |
Implementing Agencies: Democratic Republic of Ethiopia, Ministry of Health
Key Dates
Key Project Dates
Bank Approval Date: 02-Apr-2020 Effectiveness Date: 14-Apr-2020
Planned Mid Term Review Date: 11-Jul-2022 Actual Mid-Term Review Date: 28-Jul-2022
Original Closing Date: 30-Jun-2021 Revised Closing Date: 31-Dec-2025
pdoTable
Project Development Objectives
Project Development Objective (from Project Appraisal Document)
To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Ethiopia.
Has the Project Development Objective been changed since Board Approval of the Project Objective?
No
Components Table
Name
Medical Supplies and Equipment:(Cost $339.67 M)
Preparedness, Capacity Building and Training:(Cost $164.20 M)
Community Discussions and Information Outreach:(Cost $27.20 M)
Quarantine, Isolation and Treatment Centers:(Cost $146.53 M)
Project Implementation and Monitoring:(Cost $13.00 M)
Overall Ratings
Name Previous Rating Current Rating
Progress towards achievement of PDO Moderately Satisfactory Moderately Satisfactory
Overall Implementation Progress (IP) Moderately Satisfactory Moderately Satisfactory
Overall Risk Rating High High
Implementation Status and Key Decisions
The project has played a vital role in mobilizing resources for the country to rapidly strengthen its ability to prepare for and respond to the pandemic.
The project has made notable progress towards achieving the PDO in early detection and timely reporting of outbreaks, and rapid response to
infectious disease outbreaks and in making progress in several key Intermediate indicators. Three of the PDO indicators, one on early detection and
timely reporting of outbreaks and two on rapid response to infectious disease outbreaks have surpassed the end-of-project targets. Out of the total
seventeen intermediate indicators, six have exceeded their end-of-project targets, three have fully met their targets, two are on track to meet their
end targets and six indicators are lagging behind to meet the end targets. As of August 2023, the country has received 83.7 million COVID-19
vaccines (AstraZeneca, Johnson, Sino pharm, Pfizer) out of which 79.1 million have been distributed throughout the country and 70 million doses of
COVID-19 vaccines have been administered. The national coverage from the target population (12+ years) (73.9 million) is 73 percent (54 million)
that received one dose and 61 percent (44 million) completed the COVID-19 vaccination series. As regards the national coverage from the total
10/3/2023 Page 1 of 11
The World Bank Implementation Status & Results Report
Ethiopia COVID-19 Emergency Response (P173750)
population, 51 percent received at least one dose and, 42 percent completed the vaccination series out of which 51 percent are female and 49
percent male. About 6 million people received a booster dose. In relation to the special target population, a total dose of the COVID-19 vaccines has
been administered to 649,474 healthcare workers, 213,510 internally displaced people (IDPs), 45,777 refugees, and 14,874 people with disabilities.
One million doses of the COVID-19 vaccine were administered through the measles campaign, with a focus on IDPs. MOH has also made
considerable improvements under the five Project components in procurement of medical supplies and equipment, preparedness, capacity building
and training, community discussions and information outreach, renovation of Quarantine, Isolation and Treatment Centers and regulatory
infrastructure and project implementation and monitoring.
MPA Program Development Objective
MPA PDO Table
The Program Development Objective is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public
health preparedness
MPA Table
Multiphase Programmatic Approach (MPA) Status
MPA Table Body
Sustained efforts continue to be made to advance the implementation of the 87 MPA operations. After a great deal of activity (restructurings and
disbursements) processed at the end of FY23 when several operations were restructured just before or on June 30, 2023, the past month has seen a
slower period of disbursements. The overall level of disbursements is being affected by three main reasons: (i) low disbursements in six countries,
(ii) pausing of disbursements in three other countries – Afghanistan, Myanmar, and Sudan, and (iii) processing of refunds to the project accounts at
this late stage of project implementation. In addition, (i) a large refund from the UN to the project account of the Myanmar operation was processed
in late March due to the inability to implement the project, and (ii) Loans and Credits denominated in SDRs and Euros are being affected because of
fluctuations between the SDRs and Euros against the US dollar.
As of September 18, 2023, 88 MPA-projects had been approved with a total commitment of US$4.3 billion. One operation (Guatemala) was
cancelled in mid-September 2021, at the request of the Government. Total disbursements as of September 18, 2023, amount to US$3.95 billion
or 92.4% of overall commitments. This amount does not include disbursements under MPA-V operations which are reported together with AF-V
operations. Ten operations closed by the end of CY22 and nine operations closed on June 30, 2023. While there are seventeen (17) operations
with closing dates by the end of CY23, there are plans for several projects to process extensions so this number will change.
As with the Mid Term Review (MTR) issued on March 25, 2023, no individual COVID-19 MPA operation will need an ICR. Instead, one ICR
will be prepared upon completion of the SPRP COVID-19 MPA Program, which closes on December 31, 2025. The Global ICR will be based on final
ISRs packages prepared by country operations’ teams. A template for the final ISR was issued by OPCS on March 25, 2023. Several operations
have/are preparing final ISR packages. The overall conclusion of the MTR was that the COVID-19 MPA Program embodied a rapid, innovative
approach to new lending for human health response. Further, the MTR concluded that the COVID-19 MPA has been successful, notwithstanding
considerable uncertainty and multiple constraints in the early stages of the pandemic. The Bank’s emergency response was remarkably swift in the
most vulnerable countries facing human capital losses and development setbacks. The MTR also concluded that notwithstanding the challenges, the
MPA is on track to achieve its PrDO, “prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public
health preparedness.“
Seventy two (72) country projects or 84 percent of projects approved have reached 70-100+ percent disbursement (reasons for >100%
disbursements relate to fluctuations between the Euro and the SDR against the US$). Out of the 72 operations, 62 operations or 86 percent have
disbursed 90+ percent of commitments. Out of the 72 operations, 43 operations or 60 percent are fully disbursed and fourteen (14) operations
have disbursed 95-99 percent of commitments. There are four operations with disbursements of 50 percent or less. Out of these four operations,
one operation has disbursed 30 percent (AFW), two operations in EAP have disbursed 44-48 percent and one operation in AFE has disbursed 54
percent. The projects are benefitting about 3.7 billion people or 50% of the global population. When countries with AF-V operations are
10/3/2023 Page 2 of 11
The World Bank Implementation Status & Results Report
Ethiopia COVID-19 Emergency Response (P173750)
counted, the projects are benefitting about 4.1 billion of 51 percent of the global population. This is because some countries that do not have
a parent project have AF-V operations. All projects approved are disbursing. ECA has the highest percentage of disbursements at 100 percent,
followed by MNA with 99 percent, SAR with 94 percent, LAC with 93 percent, EAP with 86 percent, AFW with 84 percent and AFE with 78
percent. Disbursements for EAP operations are being affected by low disbursements in three countries. AFE lower disbursements compared to
other regions are a result of low disbursements under two operations. In the case of AFW low overall disbursements are a result of low
disbursements under one operation. Retroactive Financing (RF) continues to represent 20 percent of commitments. SAR has the highest
percentage of RF at 37 percent, followed by ECA at 18 percent. IDA continues to represent 40 percent and IBRD 60 percent of disbursements.
Streamlined procedures, delegated approvals, coupled with flexible project design and intensified efforts across the Bank have contributed to the
progress. Implementation is being guided by Bank teams working in parallel with other health related projects, including Additional Financing
operations supporting vaccine procurement and deployment efforts.
As of September 18, 2023, the Bank has approved 117 operations (including MPA-V operations) to support vaccine procurement and rollout in 78
countries amounting to $9.24 billion. The Senegal AF2 operation for $15 million financed by a Grant from The Global Finance Facility was approved
on June 30, 2023. Also, a Second AF (IDA Grant of $1.50 million) was approved on August 31, 2023 for Sao Tome and Principe. One hundred and
nineteen (119) operations had been approved amounting to $10 billion, but the: (i) Costa Rica operation ($120 million), and (ii) Peru operation ($500
million) were cancelled at the request of both governments. Also, (i) the Gabon ($12 million) reported in July as closed is still in the process of being
closed, and (ii) the Afghanistan operation commitment of $113 million was reduced to $60 million. Partial cancellations have been processed in the
past weeks under other operations, thereby the overall commitment has decreased in the past months. Of the 117 approved operations: (i) 67 are in
Africa – 31 in AFE and 36 in AFW; (ii) 10 in East Asia and the Pacific; (iii) 11 in Europe and Central Asia; (iv) 11 in Latin America and the Caribbean;
(v) 9 in Middle East and North Africa; and (vi) 9 in South Asia. The 117 operations approved, include 6 operations that involved restructuring of
parent projects (Bhutan, Cameroon, North Macedonia, Philippines, and Pakistan) and in the case of Lebanon, restructuring of the Health Resilience
Project.
Thirty-two (32) operations are being implemented in Fragile and Conflict-affected situations. IDA represents 45 percent and IBRD 55 percent of
disbursements. Total disbursements under these projects as of September 18, 2023, amount to US$6.23 billion or 68 percent of overall
commitments. Disbursements under MPA-V operations are included in this total while disbursements under the six restructured projects are
counted under parent projects. With less than planned demand for IDA/IBRD funds for vaccine procurement because, inter alia, over supply of
vaccines from donations from various sources, several projects have been/are being restructured and more will need to be restructured to reallocate
funds allocated for procurement of COVID-19 vaccines and deployment. Guidance was issued under an Email from Juan Pablo Uribe of July 7,
2023 to provide direction for the use of undisbursed funds under COVID-19 operations. HNP is monitoring progress with the implementation
of the guidelines and has presented updates on progress on the compliance with the guidelines on August 3, 2023 and September 6, 2023.
Forty-one (41) AF-V/MPA-V operations or 36 percent of operations approved have disbursed over 70 percent of their commitments. Out of the 41,
seventeen (17) operations or 41 percent have disbursed 90+. Out of the 17, four operations are fully disbursed (Argentina, Indonesia, Sri Lanka AF-
V 1, and Ukraine AF-V 3). Nine operations have disbursed 95-99 percent of commitments (Cabo Verde, Ecuador AF-V 1, Gambia AF-V 1 and 2,
Iraq, South Sudan AF-V 2, Sierra Leone AF-V 1, Turkey, and Yemen). Ninety-three (93) operations or 82 percent of total operations approved are
disbursing. ECA has the highest percentage of disbursements at 86 percent, followed by SAR and MNA at 77 percent, LAC at 76 percent, EAP at 73
percent, AFE at 58 percent and AFW at 56 percent. As of August 1, 2023, the World Bank had purchased 635.4 million doses of the COVID-19
vaccine of which 506.8 million had been delivered to client countries and 500.7 million administered.
Retroactive Financing (RF) represents 37 percent of overall commitments. High levels of RF have been authorized under different operations -
Ukraine (100%), Panama and Turkey (90%), Argentina and Guyana (80%), and Belize, and Sri Lanka (70%). One hundred and fifteen (115)
loan/financing agreements or 99 percent of projects approved have been signed and 114 or 99 percent have become effective.
As with the COVID-19 MPA operations, streamlined procedures, delegated approval, wide use of Bank Facilitated Procurement, coupled with flexible
project design, and intensified efforts across the Bank have contributed to the rapid design, processing, and implementation of the AF-V operations.
10/3/2023 Page 3 of 11
The World Bank Implementation Status & Results Report
Ethiopia COVID-19 Emergency Response (P173750)
Risks
Systematic Operations Risk-rating Tool
Risk Category Rating at Approval Previous Rating Current Rating
Political and Governance High High High
Macroeconomic High High High
Sector Strategies and Policies Moderate Moderate Moderate
Technical Design of Project or Program Moderate Moderate Moderate
Institutional Capacity for Implementation and
Substantial Substantial Substantial
Sustainability
Fiduciary High High High
Environment and Social High High High
Stakeholders Moderate Moderate Moderate
Other -- -- --
Overall High High High
Results
PDO Indicators by Objectives / Outcomes
Early detection and timely reporting of outbreaks
IN01338577
►Achieving the required timeliness of reporting for COVID-19 and other immediately reportable diseases under IDSR (Percentage, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 95.00 85.00 80.00
Date 02-Apr-2020 24-Feb-2023 22-Sep-2023 31-Dec-2025
Numerator: Number of outbreaks (COVID-19 and other immediately reportable diseases) which were
responded to within the required timelines under IDSR Denominator: Total number of outbreaks of
immediately reportable diseases.
Comments: The report timeliness was 100% for the middle of the quarter. However, in the last quarter, some facilities
were unable to report on time due to intermittent outages of the DHIS2 system, even though they acted
and reported within the stated time frame.
Rapid response to infectious disease outbreaks
IN01338578
►Percentage of priority population vaccinated, which is included in the priority population targets defined in national plan by gender
(Percentage, Custom)
10/3/2023 Page 4 of 11
The World Bank Implementation Status & Results Report
Ethiopia COVID-19 Emergency Response (P173750)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 55.00 73.00 70.00
Date 14-Jan-2021 24-Feb-2023 22-Sep-2023 31-Dec-2025
Out of the total target population (12+ years) (73.9 million), 73 percent (54 million) received one dose and
61 percent (44 million) completed the COVID-19 vaccination series. As regards the national coverage, out
of the total population, 51 percent received at least one dose and, 42 percent completed the vaccination
series out of which 51 percent are female and 49 percent male. About 6 million people received a booster
dose. In relation to the special target population, a total dose of the COVID-19 vaccines has been
Comments:
administered to 649,474 healthcare workers, 213,510 internally displaced people (IDPs), 45,777 refugees,
and 14,874 people with disabilities. One million doses of the COVID-19 vaccine were administered
through the measles campaign, with a focus on IDPs.
IN01338579
►Percentage of grievances addressed within the time specified in the project implementation manual (Percentage, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 75.00 90.00 80.00
Date 03-Dec-2021 24-Feb-2023 22-Sep-2023 31-Dec-2025
There is a functional grievance redress mechanism (GRM) systems at MOH and Project Implementing
Unit. Currently the GRM system is fully integrated with existing institutional grievance handling of the
Ministry headed by the Institutional Change Executive office. The grievance handling committee is formed
Comments:
at MOH and regional health bureau. Project implementing agencies also working in similar way to handle
the grievance handling issues related with project implementation. GRM action plan is also revised.
Intermediate Results Indicators by Components
Medical Supplies and Equipment
IN01338609
►Number of airports and PoEs received PPE supplies for airport communities and land crossing PoEs. (Number, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 51.00 13.00 18.00
Date 02-Apr-2020 24-Feb-2023 22-Sep-2023 31-Dec-2025
The Covid-19 directive has been changed, hence, there is no requirement to supply PPE to the PoEs as
Comments: there is no need for screening.
IN01338612
►Vaccine stock management tools and operating procedures updated to reflect the needs for deployment and management of COVID-19
vaccines) (Number, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 2.00 2.00 2.00
Date 14-Jan-2021 24-Feb-2023 22-Sep-2023 31-Dec-2025
10/3/2023 Page 5 of 11
The World Bank Implementation Status & Results Report
Ethiopia COVID-19 Emergency Response (P173750)
MOH’s vaccine stock management documents and operating procedures, that were conditions of
Comments: effectiveness have been submitted timely.
IN01338613
►Dry storage and cold chain capacity assessed with regards to the COVID-19 vaccines (Number, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 5.00 2.00 1.00
Date 14-Jan-2021 24-Feb-2023 22-Sep-2023 31-Dec-2025
In addition to the previous 5 assessments, the Ministry also assessed the National dry supply and cold
chain capacity of 2 health facilities. The figure represents the number of facilities whose capacity was
Comments:
assessed in this mission. The total number of assessments conducted is 7.
Preparedness, Capacity Building and Training
IN01338580
►Number of health workers, health facility facilities Surveillance focal persons, PoE screeners, and Woreda, Zonal and regional PHEM
officers trained on COVID-19. (Number, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 88.00 17,507.00 18,556.00 2,457.00
Date 02-Apr-2020 24-Feb-2023 22-Sep-2023 31-Dec-2025
The actual target surpassed the end-of-project target as a result of 1) COVID-19 health workforce
displacement and turnover that demanded additional and extensive capacity building across all pillar of
Comments: response; 2) Shift of Human resources in COVID-19 facilities and EOC that need additional capacity
building were attributed reason for more than planned performance.
IN01338597
►Number of health extension workers received orientation to strength COVID-19 community-based surveillance (Number, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 35,022.00 35,222.00 27,600.00
Date 02-Apr-2020 24-Feb-2023 22-Sep-2023 31-Dec-2025
Number of Health Extension Workers received orientation to strength COVID-19 community-based
Comments:
surveillance
IN01338599
►Number of health workers deployed for COVID-19 preparedness and response. (Number, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 96.00 3,908.00 3,908.00 1,602.00
Date 02-Apr-2020 24-Feb-2023 22-Sep-2023 31-Dec-2025
Actual data is higher than planned because there was significant displacement and turnover of health
Comments: workers due to the crises in Tigray which required additional staff deployment and training.
IN01338603
10/3/2023 Page 6 of 11
The World Bank Implementation Status & Results Report
Ethiopia COVID-19 Emergency Response (P173750)
►Number of target populations estimated who will be prioritized for access to vaccines stratified by target group (sex-disaggregated)
(Number, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 66,800,000.00 12,159,250.00 300,000.00
Date 14-Jan-2021 24-Feb-2023 22-Sep-2023 31-Dec-2025
The total target population estimated for COVID-19 vaccination was 73,918,132 (age 12 years and above)
(this is a cumulative figure). So far, MOH managed to reach 73% of the target population and 61% of the
total population remaining with 19,957,897. So MOH planned to reach 12,159,250 from the remaining
target with 1st,2nd, and booster doses. People aged 12 and above who:
have never been vaccinated,
Comments:
have not completed their primary series.
Special population group: Health workers, Older adults 55 and above, People with comorbidities
Pregnant women, Essential workers (teachers, etc), Refugees and IDPs, underserved and
marginalized groups, and youth.
IN01338606
►Guidelines, documented procedures and tools for planning and conducting vaccine pharmacovigilance activities (i.e. AEFI reporting,
investigation, causality assessment, risk communication and response) (Percentage, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 100.00 100.00 100.00
Date 14-Jan-2021 24-Feb-2023 22-Sep-2023 31-Dec-2025
IN01338610
►Percentage of adolescent population vaccinated, which is included in the priority population targets defined in national plan (Percentage,
Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 11.30 9.20 80.00
Date 11-Apr-2022 24-Feb-2023 22-Sep-2023 31-Dec-2025
The age category of the COVID-19 vaccine is from 12-17 years and 18 and above. Of the total vaccinated
Comments: population, 9.2% were adolescents aged 12-17 years (in percentage not a cumulative %).
IN01338611
►Percentage of population receiving a booster, which is included in the population targets defined in the national plan (Percentage, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 5.00 11.00 70.00
Date 11-Apr-2022 24-Feb-2023 22-Sep-2023 31-Dec-2025
The end-of-project target that was originally was over-estimated. The plan is to provide booster doses for
Comments: 15-25% of the target population who completed their vaccination series in each campaign.
Community Discussions and Information Outreach
IN01338596
►Assessment conducted to identify behavioral and socio-cultural risk factors for COVID-19 covering all the regions. (Yes/No, Custom)
Baseline Actual (Previous) Actual (Current) End Target
10/3/2023 Page 7 of 11
The World Bank Implementation Status & Results Report
Ethiopia COVID-19 Emergency Response (P173750)
Value No Yes Yes Yes
Date 02-Apr-2020 24-Feb-2023 22-Sep-2023 31-Dec-2025
Assessment conducted to identify behavioral and socio-cultural risk factors for COVID-19 covering all the
Comments: regions.
IN01338598
►Key COVID19 vaccine messages disseminated through various media outlets (radio, TV, social media, print media etc) (Number, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 380.00 2,594,936.00 20,000.00
Date 22-Jan-2021 24-Feb-2023 22-Sep-2023 31-Dec-2025
More than 2.5 million COVID-19 vaccine-related messages were developed and produced and
disseminated through different channels/media outlets to the community which are translated into different
local languages. These include Brochures, posters, banners, TV and Radio messages, social media
Comments:
messages, and short SMS which were translated into local languages.
IN01338602
Number of communication trainings conducted (Number, Custom Breakdown)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 231.00 174.00 115.00
Date 02-Mar-2021 24-Feb-2023 22-Sep-2023 31-Dec-2025
IN01338605
Number of communication material leaflets, posters, job aids, wall chart, banners) distributed (Number, Custom Breakdown)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 288,383.00 2,594,800.00 20,000.00
Date 02-Mar-2021 24-Feb-2023 22-Sep-2023 31-Dec-2025
IN01338607
►Percentage of grievances addressed within the time specified in the project implementation manual (Percentage, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 50.00 75.00 90.00 80.00
Date 13-May-2022 24-Feb-2023 22-Sep-2023 31-Dec-2025
There is a functional grievance redress mechanism (GRM) system at MOH and projecting implementing
units. Currently, the GRM system is fully integrated with the existing institutional grievance handling of the
ministry headed by the Institutional Change Executive office. The grievance handling committee is formed
Comments:
at MOH and the regional health bureau. Project implementing agencies also work in a similar way to
handle the grievance handling issues related to project implementation. GRM action plan is also revised.
Isolation and Quarantine Centers
IN01338601
10/3/2023 Page 8 of 11
The World Bank Implementation Status & Results Report
Ethiopia COVID-19 Emergency Response (P173750)
►Number of vaccine laboratory renovated and equipped. (Number, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 0.00 0.00 1.00
Date 14-Jan-2021 13-Sep-2022 22-Sep-2023 31-Dec-2025
The renovation of the vaccine laboratory has begun and has reached 11% completion.
Comments:
Project Management and Monitoring
IN01338600
►Number of monthly assessed (using checklist) PoEs, isolation and quarantine centers (Number, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 185.00 13.00 192.00
Date 02-Apr-2020 24-Feb-2023 22-Sep-2023 31-Dec-2025
Following the integration of COVID-19, the isolation and quarantine centers are no longer operational.
However, all existing 13 PoEs are providing daily reporting, getting daily feedback, and quarterly
Comments:
supportive supervision.
IN01338604
►Percentage of complaints to the Grievance Redress Mechanism (GRM) satisfactorily addressed within 15 weeks of initial complaint being
recorded (Percentage, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value 0.00 75.00 80.00 90.00
Date 02-Apr-2020 24-Feb-2023 22-Sep-2023 31-Dec-2025
The functional GRM system at MOH and the Project implementing unit is in place which is fully integrated
Comments: with the existing grievance handling of MOH headed by the Institutional Change Executive Office.
IN01338608
►Distribution of female PPE matches daily needs of female workers (Yes/No, Custom)
Baseline Actual (Previous) Actual (Current) End Target
Value No Yes Yes Yes
Date 22-Feb-2021 24-Feb-2023 22-Sep-2023 31-Dec-2025
Performance-Based Conditions
Data on Financial Performance
Disbursements (by loan)
10/3/2023 Page 9 of 11
The World Bank Implementation Status & Results Report
Ethiopia COVID-19 Emergency Response (P173750)
Project Loan/Credit/TF Status Currency Original Revised Cancelled Disbursed Undisbursed % Disbursed
P173750 IDA-65870 Effective USD 41.30 41.30 0.00 40.01 2.05 95%
P173750 IDA-D5940 Effective USD 41.30 41.30 0.00 41.86 0.00 100%
P173750 IDA-D7910 Effective USD 207.00 207.00 0.00 123.52 68.94 64%
P173750 IDA-D9550 Effective USD 206.00 206.00 0.00 72.37 120.20 38%
P173750 IDA-E0640 Effective USD 195.00 195.00 0.00 77.55 115.40 40%
Key Dates (by loan)
Project Loan/Credit/TF Status Approval Date Signing Date Effectiveness Date Orig. Closing Date Rev. Closing Date
P173750 IDA-65870 Effective 02-Apr-2020 03-Apr-2020 14-Apr-2020 30-Jun-2021 31-Dec-2025
P173750 IDA-D5940 Effective 02-Apr-2020 03-Apr-2020 14-Apr-2020 30-Jun-2021 31-Dec-2025
P173750 IDA-D7910 Effective 26-Mar-2021 23-Apr-2021 08-Jun-2021 31-Dec-2023 31-Dec-2025
P173750 IDA-D9550 Effective 20-Dec-2021 10-Feb-2022 01-Mar-2022 31-Oct-2024 31-Dec-2025
P173750 IDA-E0640 Effective 31-May-2022 17-Jun-2022 13-Oct-2022 31-Dec-2025 31-Dec-2025
Cumulative Disbursements
10/3/2023 Page 10 of 11
The World Bank Implementation Status & Results Report
Ethiopia COVID-19 Emergency Response (P173750)
Restructuring History
There has been no restructuring to date.
Related Project(s)
P175853-Additional Financing for Ethiopia COVID-19 Emergency Response Project ,P177906-Second AF for the Ethiopia Covid-19 Emergency
Response Project ,P178821-Third Additional Financing for the Ethiopia COVID-19 Emergency Response Project
10/3/2023 Page 11 of 11